11 Mins Ago Novozymes CEO is confident its merger with Chr. Hansen will close in Q1 Novozymes CEO Ester Baiget discusses the Danish biotechnology company’s planned combination with with fellow biotech firm Chr. Hansen. An Hour Ago UBS CEO: Markets too complacent about rate cuts Sergio Ermotti, CEO of UBS, outlines the main challenges the